Call for annual mammograms for hormone replacement therapy (HRT) women in Spain:
This article was originally published in Clinica
Menopausal women in Spain who are taking hormone replacement therapy should undergo annual mammographies, said experts speaking at the IV National Congress on the Menopause in Santander. While the relationship between breast cancer and HRT is unclear, there may be a slight rise in the risk in women taking HRT for more than five years, observed Constantino Ribes, president of the congress and head of the menopause unit at Santander's Marques de Valdecilla hospital.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.